{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:22:37Z","timestamp":1789024957857,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s12020-018-1548-x","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T07:14:07Z","timestamp":1517901247000},"page":"373-383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review"],"prefix":"10.1007","volume":"60","author":[{"given":"Panagiotis","family":"Anagnostis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula A.","family":"Paschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nifon N.","family":"Gkekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini-Maria","family":"Artzouchaltzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Christou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Stogiannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andromachi","family":"Vryonidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Potoupnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"key":"1548_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF02556109","volume":"49","author":"R Bouillon","year":"1991","unstructured":"R. Bouillon, Diabetic bone disease. Calcif. Tissue Int. 49, 155\u2013160 (1991)","journal-title":"Calcif. Tissue Int."},{"key":"1548_CR2","doi-asserted-by":"publisher","unstructured":"S.A. Paschou, P. Anagnostis, A. Vryonidou, D.G. Goulis, Editorial: Diabetes and atherosclerosis: old players in a new field, osteoporosis. Curr. Vasc. Pharmacol. (2017). \n                    https:\/\/doi.org\/10.2174\/1570161116666171205104851","DOI":"10.2174\/1570161116666171205104851"},{"key":"1548_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bone.2008.03.017","volume":"43","author":"S Epstein","year":"2008","unstructured":"S. Epstein, D. Leroith, Diabetes and fragility fractures\u2013a burgeoning epidemic? Bone 43, 3\u20136 (2008)","journal-title":"Bone"},{"key":"1548_CR4","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2337\/diab.44.7.775","volume":"44","author":"JC Krakauer","year":"1995","unstructured":"J.C. Krakauer, M.J. McKenna, N.F. Buderer, D.S. Rao, F.W. Whitehouse, A.M. Parfitt, Bone loss and bone turnover in diabetes. Diabetes 44, 775\u2013782 (1995)","journal-title":"Diabetes"},{"key":"1548_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/aje\/kwm106","volume":"166","author":"M Janghorbani","year":"2007","unstructured":"M. Janghorbani, R.M. Van Dam, W.C. Willett, F.B. Hu, Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am. J. Epidemiol. 166, 495\u2013505 (2007)","journal-title":"Am. J. Epidemiol."},{"key":"1548_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"P. Vestergaard, Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos. Int. 18, 427\u2013444 (2007)","journal-title":"Osteoporos. Int."},{"key":"1548_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"J.A. Kanis, O. Johnell, A. Oden, H. Johansson, E. McCloskey, FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos. Int. 19, 385\u2013397 (2008)","journal-title":"Osteoporos. Int."},{"key":"1548_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1589\/jpts.27.179","volume":"27","author":"C Adil","year":"2015","unstructured":"C. Adil, T. Ayd\u0131n, \u00d6. Ta\u015fp\u0131nar, et al., Bone mineral density evaluation of patients with type 2 diabetes mellitus. J. Phys. Ther. Sci. 27, 179\u2013182 (2015).","journal-title":"J. Phys. Ther. Sci."},{"key":"1548_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.6118\/jmm.2015.21.1.36","volume":"21","author":"EK Caglayan","year":"2015","unstructured":"E.K. Caglayan, Y. Engin-Ustun, N. Sari, S. Karacavus, L. Seckin, M. Kara, Evaluation of bone density measurement in type 2 diabetic postmenopausal women with hypertension and hyperlipidemia. J. Menopausa. Med. 21, 36\u201340 (2015)","journal-title":"J. Menopausa. Med."},{"key":"1548_CR10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/jbmr.2106","volume":"29","author":"JN Farr","year":"2014","unstructured":"J.N. Farr, M.T. Drake, S. Amin, L.J. Melton 3rd, L.K. McCready, S. Khosla, In vivo assessment of bone quality in postmenopausal women with type 2 diabetes. J. Bone Miner. Res. 29, 787\u2013795 (2014)","journal-title":"J. Bone Miner. Res."},{"key":"1548_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/obr.12244","volume":"16","author":"V Mpalaris","year":"2015","unstructured":"V. Mpalaris, P. Anagnostis, D.G. Goulis, I. Iakovou, Complex association between body weight and fracture risk in postmenopausal women. Obes. Rev. 16, 225\u2013233 (2015)","journal-title":"Obes. Rev."},{"key":"1548_CR12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrendo.2016.153","volume":"13","author":"N Napoli","year":"2017","unstructured":"N. Napoli, M. Chandran, D.D. Pierroz, B. Abrahamsen, A.V. Schwartz, S.L. Ferrari; IOF Bone and Diabetes Working Group, Mechanisms of diabetes mellitus-induced bone fragility. Nat. Rev. Endocrinol. 13, 208\u2013219 (2017)","journal-title":"Nat. Rev. Endocrinol."},{"key":"1548_CR13","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1210\/jc.2017-00042","volume":"102","author":"SA Paschou","year":"2017","unstructured":"S.A. Paschou, A.D. Dede, P. Anagnostis, A. Vryonidou, D. Morganstein, D.G. Goulis, Type 2 diabetes and osteoporosis: a guide to optimal management. J. Clin. Endocrinol. Metab. 102, 3621\u20133634 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1548_CR14","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"A. Liberati, D.G. Altman, J. Tetzlaff et al., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339, 2700 (2009)","journal-title":"BMJ"},{"key":"1548_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"A. Stang, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25, 603\u2013605 (2010).","journal-title":"Eur. J. Epidemiol."},{"key":"1548_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00223-010-9450-4","volume":"88","author":"P Vestergaard","year":"2011","unstructured":"P. Vestergaard, L. Rejnmark, L. Mosekilde, Are antiresorptive drugs effective against fractures in patients with diabetes? Calcif. Tissue Int. 88, 209\u2013214 (2011)","journal-title":"Calcif. Tissue Int."},{"key":"1548_CR17","first-page":"2","volume":"64","author":"R Nan","year":"2016","unstructured":"R. Nan, D. Grigorie, A. Cursaru et al., Bisphosphonates-a good choice for women with type 2 diabetes and postmenopausal osteoporosis? Farmacia 64, 2 (2016)","journal-title":"Farmacia"},{"key":"1548_CR18","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2337\/diacare.27.7.1547","volume":"27","author":"TH Keegan","year":"2004","unstructured":"T.H. Keegan, A.V. Schwartz, D.C. Bauer, D.E. Sellmeyer, J.L. Kelsey, Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial. Diabetes Care 27, 1547\u20131553 (2004)","journal-title":"Diabetes Care"},{"key":"1548_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.diabres.2011.03.033","volume":"93","author":"J Iwamoto","year":"2011","unstructured":"J. Iwamoto, Y. Sato, M. Uzawa, T. Takeda, H. Matsumoto, Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without type 2 diabetes. Diabetes Res. Clin. Pract. 93, 166\u2013173 (2011)","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1548_CR20","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1007\/BF02877778","volume":"24","author":"S Dagdelen","year":"2007","unstructured":"S. Dagdelen, D. Sener, M. Bayraktar, Influence of type 2 diabetes mellitus on bone mineral density response to bisphosphonates in late postmenopausal osteoporosis. Adv. Ther. 24, 1314\u20131320 (2007)","journal-title":"Adv. Ther."},{"key":"1548_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s00223-015-0071-9","volume":"98","author":"D Inoue","year":"2016","unstructured":"D. Inoue, R. Muraoka, R. Okazaki, Y. Nishizawa, T. Sugimoto, Efficacy and safety of risedronate in osteoporosis subjectswith comorbid diabetes, hypertension, and\/or dyslipidemia: a post hoc analysis of phase III trials conducted in Japan. Calcif. Tissue Int. 98, 114\u2013122 (2016)","journal-title":"Calcif. Tissue Int."},{"key":"1548_CR22","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1359\/jbmr.040211","volume":"19","author":"O Johnell","year":"2004","unstructured":"O. Johnell, J.A. Kanis, D.M. Black et al., Associations between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study. J. Bone Miner. Res. 19, 764\u2013772 (2004)","journal-title":"J. Bone Miner. Res."},{"key":"1548_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1359\/jbmr.070904","volume":"23","author":"KE Ensrud","year":"2008","unstructured":"K.E. Ensrud, J.L. Stock, E. Barrett-Connor et al., Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial. J. Bone Miner. Res. 23, 112\u2013120 (2008)","journal-title":"J. Bone Miner. Res."},{"key":"1548_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bone.2016.06.017","volume":"91","author":"AV Schwartz","year":"2016","unstructured":"A.V. Schwartz, I. Pavo, J. Alam et al., Teriparatide in patients with osteoporosis and type 2 diabetes. Bone 91, 152\u2013158 (2016)","journal-title":"Bone"},{"key":"1548_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2147\/TCRM.S131945","volume":"13","author":"A Moayeri","year":"2017","unstructured":"A. Moayeri, M. Mohamadpour, S.F. Mousavi, E. Shirzadpour, S. Mohamadpour, M. Amraei, Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Ther. Clin. Risk. Manag. 13, 455\u2013468 (2017)","journal-title":"Ther. Clin. Risk. Manag."},{"key":"1548_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40520-016-0562-1","volume":"29","author":"J Dytfeld","year":"2017","unstructured":"J. Dytfeld, M. Michalak, Type 2 diabetes and risk of low-energy fractures in postmenopausal women: meta-analysis of observational studies. Aging Clin. Exp. Res. 29, 301\u2013309 (2017)","journal-title":"Aging Clin. Exp. Res."},{"key":"1548_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00198-015-3279-7","volume":"27","author":"Y Fan","year":"2016","unstructured":"Y. Fan, F. Wei, Y. Lang, Y. Liu, Diabetes mellitus and risk of hip fractures: a meta-analysis. Osteoporos. Int. 27, 219\u2013228 (2016)","journal-title":"Osteoporos. Int."},{"key":"1548_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.maturitas.2014.08.003","volume":"79","author":"EA Waard De","year":"2014","unstructured":"E.A. De Waard, T.A. Van Geel, H.H. Savelberg, A. Koster, P.P. Geusens, J.P. van den Bergh, Increased fracture risk in patients with type 2 diabetes mellitus: an overview of the underlying mechanisms and the usefulness of imaging modalities and fracture risk assessment tools. Maturitas 79, 265\u2013274 (2014)","journal-title":"Maturitas"},{"key":"1548_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10654-012-9674-x","volume":"27","author":"L Ma","year":"2012","unstructured":"L. Ma, L. Oei, L. Jiang et al., Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur. J. Epidemiol. 27, 319\u2013332 (2012)","journal-title":"Eur. J. Epidemiol."},{"key":"1548_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s00223-016-0191-x","volume":"100","author":"GI Schacter","year":"2017","unstructured":"G.I. Schacter, W.D. Leslie, DXA-based measurements in diabetes: can they predict fracture risk? Calcif. Tissue Int. 100, 150\u2013164 (2017)","journal-title":"Calcif. Tissue Int."},{"key":"1548_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jbmr.556","volume":"27","author":"LM Giangregorio","year":"2012","unstructured":"L.M. Giangregorio, W.D. Leslie, L.M. Lix, H. Johansson, A. Oden, E. McCloskey, J.A. Kanis, FRAX underestimates fracture risk in patients with diabetes. J. Bone Miner. Res. 27, 301\u20138 (2012)","journal-title":"J. Bone Miner. Res."},{"issue":"21","key":"1548_CR32","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1001\/jama.2011.715","volume":"305","author":"AV Schwartz","year":"2011","unstructured":"A.V. Schwartz, E. Vittinghoff, D.C. Bauer, T.A. Hillier, E.S. Strotmeyer, K.E. Ensrud, M.G. Donaldson, J.A. Cauley, T.B. Harris, A. Koster, C.R. Womack, L. Palermo, D.M. Black, Study of Osteoporotic Fractures (SOF) Research Group; Osteoporotic Fractures in Men (MrOS) Research Group; Health, Aging, and Body Composition (Health ABC) Research Group. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 305(21), 2184\u201392 (2011)","journal-title":"JAMA"},{"key":"1548_CR33","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1210\/jc.2014-2047","volume":"100","author":"JH Kim","year":"2015","unstructured":"J.H. Kim, H.J. Choi, E.J. Ku et al., Trabecular bone score as an indicator for skeletal deterioration in diabetes. J. Clin. Endocrinol. Metab. 100, 475\u2013482 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"1548_CR34","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1210\/jc.2012-3118","volume":"98","author":"WD Leslie","year":"2013","unstructured":"W.D. Leslie, B. Aubry-Rozier, O. Lamy, D. Hans, Manitoba bone density program. TBS (trabecular bone score) and diabetes-related fracture risk. J. Clin. Endocrinol. Metab. 98(2), 602\u20139 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1548_CR35","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1210\/jc.2010-0226","volume":"95","author":"AJ Burghardt","year":"2010","unstructured":"A.J. Burghardt, A.S. Issever, A.V. Schwartz et al., High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 95, 5045\u20135055 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1548_CR36","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/jbmr.3057","volume":"32","author":"AG Nilsson","year":"2017","unstructured":"A.G. Nilsson, D. Sundh, L. Johansson et al., Type 2 diabetes mellitus is associated with better bone microarchitecture but lower bone material Strength and poorer physical function in elderly women: a population-based Study. J. Bone Miner. Res. 32, 1062\u20131071 (2017)","journal-title":"J. Bone Miner. Res."},{"key":"1548_CR37","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00198-014-2676-7","volume":"25","author":"J Starup-Linde","year":"2014","unstructured":"J. Starup-Linde, S.A. Eriksen, S. Lykkeboe, A. Handberg, P. Vestergaard, Biochemical markers of bone turnover in diabetes patients-a meta-analysis, and a methodological study on the effects of glucose on bone markers. Osteoporos 25, 1697\u20131708 (2014)","journal-title":"Osteoporos"},{"key":"1548_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fendo.2013.00021","volume":"4","author":"J Starup-Linde","year":"2013","unstructured":"J. Starup-Linde, Diabetes, biochemical markers of bone turnover, diabetes control, and bone. Front. Endocrinol. 4, 21 (2013)","journal-title":"Front. Endocrinol."},{"key":"1548_CR39","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1007\/s00198-017-4097-x","volume":"28","author":"VN Shah","year":"2017","unstructured":"V.N.Shah, K.K.Harrall, C.S.Shah, et al., Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature. Osteoporos. Int 28, 2601\u20132610 (2017).","journal-title":"Osteoporos. Int"},{"key":"1548_CR40","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1210\/jc.2015-3882","volume":"101","author":"J Starup-Linde","year":"2016","unstructured":"J. Starup-Linde, S. Lykkeboe, S. Gregersen et al., Bone structure and predictors of fracture in type 1 and type 2 diabetes. J. Clin. Endocrinol. Metab. 101, 928\u2013936 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1548_CR41","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1210\/jc.2017-00620","volume":"102","author":"C Verroken","year":"2017","unstructured":"C. Verroken, W. Pieters, L. Beddeleem et al., Cortical bone size deficit in adult patients with type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 102, 2887\u20132895 (2017)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1548_CR42","first-page":"66","volume":"17","author":"MM Campos Pastor","year":"2008","unstructured":"M.M. Campos Pastor, J.D. Luna, F. Escobar-Jimenez, F.J. Gomez Jimenez, M.D. Serrano Pardo, P. Lopez-Ibarra, Effects of risedronate on metabolic bone disease in patients with type 1 diabetes and osteoporosis. Rev. Esp. Enferm. Metab. Oseas. 17, 66\u201370 (2008)","journal-title":"Rev. Esp. Enferm. Metab. Oseas."},{"key":"1548_CR43","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/j.1463-1326.2010.01225.x","volume":"12","author":"RE Aubert","year":"2010","unstructured":"R.E. Aubert, V. Herrera, W. Chen, S.M. Haffner, M. Pendergrass, Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes. Diabetes Obes. Metab. 12, 716\u2013721 (2010)","journal-title":"Diabetes Obes. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1548-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1548-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1548-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T19:29:28Z","timestamp":1549394968000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1548-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["1548"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1548-x","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,6]]},"assertion":[{"value":"6 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}